Study Guide for Clayton's Basic Pharmacology for Nurses - Elsevier E-Book on VitalSource, 20th Edition

by Michelle J. Willihnganz, MS, RN, CNE

Elsevier eBook on VitalSource

ISBN: 9780443264078

Publication Date: 03-25-2025

Page Count: 216

Imprint: Elsevier

List Price: $36.99

Was $36.99

Now $32.55

Or $0.00 with a valid access code

Reinforce your understanding of nursing pharmacology and prepare for success on the NCLEX-PN^® exam! With chapters corresponding to the chapters in Clayton’s Basic Pharmacology for Nurses, 20^th Edition, this study guide provides a variety of exercises to help you review and practice the LPN/LVN’s role in drug therapy and patient care. Review questions make it easier to achieve the chapter objectives from the textbook, and patient scenarios help you develop clinical judgment skills. Next Generation NCLEX^® (NGN)-style questions ensure that you will be ready for the critical thinking questions on the NGN exam.

Related Products
- 20th Edition
  Clayton’s Basic Pharmacology for Nurses
  Paperback
  
  ISBN: 9780443126994
- 20th Edition
  Clayton’s Basic Pharmacology for Nurses - Elsevier E-Book on VitalSource
  Elsevier eBook on VitalSource
  
  ISBN: 9780443263996
Key Features
- NEW! Three new chapters address key topics: Drugs Used to Treat Immune and Inflammatory Disorders; Drugs Used to Treat Headaches; and Drugs Used to Treat Attention Deficit Hyperactivity Disorder
- NEW! Updated exercises cover the new content in the text, including newly approved pharmaceutical drugs and treatments
- Case scenarios in clinical chapters allow you to review, practice, and apply clinical judgment skills
- Reader-friendly writing style and organization make it easier to review and practice nursing pharmacology concepts
- A variety of exercises, including matching, multiple-choice, select-all-that-apply, and Next Generation NCLEX^® (NGN)-style questions help reinforce your understanding of key content
Contents

1. Basic Principles of Pharmacology
2. Drug Actions Across the Life Span
3. The Nursing Process and Pharmacology
4. Patient Education to Promote Health
5. Principles of Medication Administration and Medication Safety
6. Percutaneous Administration
7. Enteral Administration
8. Parenteral Administration: Safe Preparation
9. Parenteral Administration: Intradermal, Subcutaneous, and Intramuscular
10. Parenteral Administration: Intravenous
11. Drugs Affecting the Central and Peripheral Nervous System
12. Drugs Used to Treat Neurodegenerative Disorders
13. Drugs Used to Treat Seizure Disorders
14. Drugs Used to Treat Headaches
15. Drugs Used to Treat Pain: Focus on Opioids
16. Drugs Used to Treat Attention-Deficit Hyperactivity Disorder
17. Drugs Used to Treat Substance Use Disorders
18. Drugs Used to Treat Schizophrenia
19. Drugs Used to Treat Depressive and Bipolar Disorders
20. Drugs Used to Treat Anxiety Disorders
21. Drugs Used to Treat Sleep Disorders
22. Drugs Used to Treat Dyslipidemias
23. Drugs Used to Treat Hypertension
24. Drugs Used to Treat Arrhythmias
25. Drugs Used to Treat Angina Pectoris
26. Drugs Used to Treat Peripheral Vascular Disease
27. Drugs Used to Treat Thromboembolic Disorders
28. Drugs Used to Treat Heart Failure
29. Drugs Used to Treat Upper Respiratory Disease
30. Drugs Used to Treat Lower Respiratory Disease
31. Drugs Used to Treat Gastroesophageal Reflux and Peptic Ulcer Disease
32. Drugs Used to Treat Nausea and Vomiting
33. Drugs Used to Treat Constipation and Diarrhea
34. Drugs Used to Treat Diabetes Mellitus
Authors

Michelle J. Willihnganz, MS, RN, CNE, RCTC Nursing Instructor, Rochester Community and Technical College, Rochester, Minnesota
Accessibility
- Ways of Reading
  - The appearance of the text and page layout can be modified according to the capabilities of the reading system (font family and font size, spaces between paragraphs, sentences, words, and letters, as well as color of background and text)
  - This e-publication is accessible to the full extent that the file format and types of content allow, on a specific reading device, by default, without necessarily including any additions such as textual descriptions of images or enhanced navigation
  - No information about nonvisual reading is available
- Conformance
  - For detailed accessibility information, see Elsevier's website at https://www.elsevier.com/about/accessibility
  - For queries regarding accessibility information, contact [email protected]
  - The publication was certified on 18-11-2025
- Navigation
  - Table of contents to all chapters of the text via links
- Rich Content
  - No information is available
- Hazards
  - No information is available
- Product Content
  - No information is available
- Legal Considerations
  - No information is available
- Additional Accessibility Information
  - For readers with color vision deficiency, use of color (e.g., in diagrams, graphics and charts, in prompts, or on buttons inviting a response) is not the sole means of graphical distinction or of conveying information
  - E-publication includes basic navigation (usually less detailed than TOC-based navigation)
  - Where links, controls or buttons are included in the content, the purpose or functionality of each link, control or button is apparent from the associated text alone - or where it is unclear, separate link, control or button descriptions are provided
  - All (or substantially all) textual matter is arranged in a single logical reading order (including text that is visually presented as separate from the main text flow, e.g., in boxouts, captions, tables, footnotes, endnotes, citations, etc.). Non-textual content is also linked from within this logical reading order. (Purely decorative non-text content can be ignored).
  - The language of the text has been specified (e.g., via the HTML or XML lang attribute) to optimise text-to-speech (and other alternative renderings), both at the whole document level and, where appropriate, for individual words, phrases or passages in a different language.